Rallybio inks $145m Series B
New Haven, Connecticut-based Rallybio, a biopharmaceutical company, has closed $145 million in Series B funding.
New Haven, Connecticut-based Rallybio, a biopharmaceutical company, has closed $145 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination